Yiyi Yan

1.4k total citations
38 papers, 878 citations indexed

About

Yiyi Yan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Yiyi Yan has authored 38 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 20 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Yiyi Yan's work include Cancer Immunotherapy and Biomarkers (21 papers), CAR-T cell therapy research (13 papers) and Immunotherapy and Immune Responses (9 papers). Yiyi Yan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), CAR-T cell therapy research (13 papers) and Immunotherapy and Immune Responses (9 papers). Yiyi Yan collaborates with scholars based in United States, China and Finland. Yiyi Yan's co-authors include Svetomir N. Markovic, Haidong Dong, Roxana Dronca, Sean S. Park, Anagha Kumar, Heidi D. Finnes, Susan M. Harrington, Xiaoshan Zhang, Aaron S. Mansfield and Randy J. Legerski and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Yiyi Yan

37 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yiyi Yan United States	13	496	454	248	141	128	38	878
Shafinaz Hussein United States	9	419 0.8×	489 1.1×	428 1.7×	347 2.5×	158 1.2×	31	1.1k
Ludger Große‐Hovest Germany	19	655 1.3×	712 1.6×	282 1.1×	61 0.4×	84 0.7×	46	1.2k
Bangxing Hong United States	18	445 0.9×	578 1.3×	344 1.4×	52 0.4×	37 0.3×	37	1.0k
Deanna M. Grote United States	13	546 1.1×	698 1.5×	212 0.9×	349 2.5×	233 1.8×	23	1.4k
Karin Schreiber United States	19	544 1.1×	582 1.3×	218 0.9×	50 0.4×	63 0.5×	43	1.1k
Sarah L. Buchan United Kingdom	18	434 0.9×	829 1.8×	392 1.6×	60 0.4×	34 0.3×	26	1.1k
Susanne H.C. Baumeister United States	10	637 1.3×	598 1.3×	175 0.7×	50 0.4×	31 0.2×	19	1.0k
Jean A. Yared United States	15	463 0.9×	206 0.5×	205 0.8×	133 0.9×	54 0.4×	66	838
Elisabetta Dondi France	15	256 0.5×	348 0.8×	218 0.9×	38 0.3×	113 0.9×	34	723

Countries citing papers authored by Yiyi Yan

Since Specialization

Citations

This map shows the geographic impact of Yiyi Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiyi Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiyi Yan more than expected).

Fields of papers citing papers by Yiyi Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiyi Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiyi Yan. The network helps show where Yiyi Yan may publish in the future.

Co-authorship network of co-authors of Yiyi Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Yiyi Yan. A scholar is included among the top collaborators of Yiyi Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiyi Yan. Yiyi Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McWilliams, Robert R., et al.. (2024). Efficacy and toxicity of KIT targeted therapy in elderly patients with melanoma.. Journal of Clinical Oncology. 42(16_suppl). e23269–e23269. 1 indexed citations

Barham, Whitney, Xin Liu, Susan M. Harrington, et al.. (2023). A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration–Approved PD-1 and PD-L1 Inhibitors. ImmunoHorizons. 7(1). 125–139. 6 indexed citations

Barham, Whitney, Ying Li, Xin Liu, et al.. (2023). DUSP2 functions as a negative regulator of cytotoxic T cell responses in cancer immunotherapy. The Journal of Immunology. 210(Supplement_1). 171.06–171.06. 1 indexed citations

Smith, Katherine E., Adam J. Weisbrod, Carrie Strand, et al.. (2023). Abstract CT207: Phase I trial of vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 (VSV-IFNb-TYRP1) in metastatic ocular melanoma. Cancer Research. 83(8_Supplement). CT207–CT207. 1 indexed citations

Dumic, Igor, et al.. (2023). Immune Checkpoint Inhibitor-Induced Pure Red Cell Aplasia: A Review of 2 Cases in Metastatic Melanoma. American Journal of Case Reports. 24. e941789–e941789. 3 indexed citations

Leontovich, Alexey A., Raymond M. Moore, Wendy K. Nevala, et al.. (2022). Resolving the Heterogeneous Tumor-Centric Cellular Neighborhood through Multiplexed, Spatial Paracrine Interactions in the Setting of Immune Checkpoint Blockade. Cancer Research Communications. 2(2). 78–89. 6 indexed citations

Barham, Whitney, Ruifeng Guo, Sean S. Park, et al.. (2021). Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor Therapy. Frontiers in Immunology. 11. 561083–561083. 13 indexed citations

Yan, Yiyi, Xingchen Huo, Taoshan Ai, & Jianguo Su. (2020). β-glucan and anisodamine can enhance the immersion immune efficacy of inactivated cyprinid herpesvirus 2 vaccine in Carassius auratus gibelio. Fish & Shellfish Immunology. 98. 285–295. 39 indexed citations

Yan, Yiyi. (2020). Immuno-Oncology Essentials: Applications in Clinical Scenarios—Introduction. JCO Oncology Practice. 16(2_suppl). 1s–3s. 1 indexed citations

10.

Barham, Whitney, Joanina K. Gicobi, Yiyi Yan, Roxana Dronca, & Haidong Dong. (2019). Paradox-driven adventures in the development of cancer immunology and immunotherapy. Genes & Diseases. 6(3). 224–231. 4 indexed citations

11.

Paludo, Jonas, Lisa A. Kottschade, Jessica E. Brandt, et al.. (2019). Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine. Supportive Care in Cancer. 27(10). 3869–3875. 5 indexed citations

12.

Venkatesh, Sudhakar K., et al.. (2019). SOS! Immunotherapy-Associated Sinusoidal Obstructive Syndrome. Journal of Oncology Practice. 15(12). 675–676. 2 indexed citations

13.

Yan, Yiyi, Anagha Kumar, Heidi D. Finnes, et al.. (2018). Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy. Frontiers in Immunology. 9. 1739–1739. 182 indexed citations

14.

Yan, Yiyi, Siyu Cao, Xin Liu, et al.. (2018). CX3CR1 identifies PD-1 therapy–responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy. JCI Insight. 3(8). 96 indexed citations

15.

Wu, Xiaosheng, Yanli Li, Xin Liu, et al.. (2018). Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy. Heliyon. 4(12). e01039–e01039. 43 indexed citations

16.

Jakub, James W., Jennifer M. Racz, Tina J. Hieken, et al.. (2017). Neoadjuvant systemic therapy for regionally advanced melanoma. Journal of Surgical Oncology. 117(6). 1164–1169. 12 indexed citations

17.

Grothey, Axel & Yiyi Yan. (2015). Molecular profiling in the treatment of colorectal cancer: focus on regorafenib. OncoTargets and Therapy. 8. 2949–2949. 12 indexed citations

18.

Yan, Yiyi, Thomas L. Olson, Susan B. Nyland, David J. Feith, & Thomas P. Loughran. (2014). Emergence of a STAT3 mutated NK clone in LGL leukemia. Leukemia Research Reports. 4(1). 4–7. 7 indexed citations

19.

Rajala, Hanna, Samuli Eldfors, Heikki Kuusanmäki, et al.. (2013). Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood. 121(22). 4541–4550. 195 indexed citations

20.

Yan, Yiyi, Xiaoshan Zhang, & Randy J. Legerski. (2011). Artemis interacts with the Cul4A-DDB1 ^DDB2 ubiquitin E3 ligase and regulates degradation of the CDK inhibitor p27. Cell Cycle. 10(23). 4098–4109. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact